These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3094454)

  • 1. [Comparison of continuous venous infusion of 5-FU and FT-207 under total parenteral nutrition].
    Tane S; Ogawa Y; Kido Y; Naruko M; Niwa H; Abe Y; Kobayashi M; Mori T
    Gan To Kagaku Ryoho; 1986 Oct; 13(10):2947-53. PubMed ID: 3094454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Continuous venous infusion of 5-fluorouracil (5-FU) under total parenteral nutrition (TPN) in advanced gastric cancer].
    Tane S; Ogawa Y; Kido Y; Ogawa M; Shiozaki H; Miyamoto T; Kokunai I; Watase M; Mori T
    Gan To Kagaku Ryoho; 1985 Dec; 12(12):2322-6. PubMed ID: 3935052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Invention of a tumor-selective 5-fluorouracil derivative named S-1 by biochemical modulation of 5-fluorouracil].
    Shirasaka T; Shimamoto Y; Kato T; Fukushima M
    Gan To Kagaku Ryoho; 1998 Feb; 25(3):371-84. PubMed ID: 9492831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The mechanism of potentiation of the antitumor effect of 5-fluorouracil by methionine-free intravenous amino acid solution (AO-90) in rats].
    Hibino Y; Kawarabayashi Y; Kohri H; Ueda N; Tsukagoshi S
    Gan To Kagaku Ryoho; 1994 Sep; 21(12):2021-8. PubMed ID: 8085853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of intravenous alimentation on adjuvant chemotherapy--an experimental study on the distribution of 5-FU after injection of tegafur (2)].
    Kimoto M; Nagano H; Sano K
    Gan To Kagaku Ryoho; 1987 Oct; 14(10):2859-64. PubMed ID: 3116943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous intravenous administration of 1-(2-tetrahydrofuryl)-5-fluorouracil [FT] by intravenous hyperalimentation (IVH)--stability of FT in IVH solution and tumor levels of 5-fluorouracil (5-FU).
    Moriya Y; Koyama Y; Hojo K; Tsunematsu R
    Jpn J Clin Oncol; 1983 Mar; 13(1):31-5. PubMed ID: 6403740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of 5-fluorouracil pharmacokinetics in patients receiving continuous 5-fluorouracil infusion and oral uracil plus N1-(2'-tetrahydrofuryl)-5-fluorouracil.
    Ho DH; Pazdur R; Covington W; Brown N; Huo YY; Lassere Y; Kuritani J
    Clin Cancer Res; 1998 Sep; 4(9):2085-8. PubMed ID: 9748123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relevance of the pharmacology of oral tegafur to its use as a 5-FU pro-drug.
    Byfield JE; Hornbeck CL; Frankel SS; Sharp TR; Griffiths JC
    Cancer Treat Rep; 1985 Jun; 69(6):645-52. PubMed ID: 3926308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experimental studies on the optimal therapeutic mode of intra-arterial infusion of 5-fluorouracil. (2) Concentrations within the tumors and normal tissues and therapeutic and adverse effects of 5-fluorouracil delivered by various routes].
    Ota J
    Gan To Kagaku Ryoho; 1983 Nov; 10(11):2362-9. PubMed ID: 6639098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical study on the permeability of FT-207 and 5-FU in primary lung cancer].
    Aogauchi R; Tsubota N; Yamashita C; Yoshikawa K; Ishii N; Nakamura K
    Gan To Kagaku Ryoho; 1985 Jan; 12(1):105-10. PubMed ID: 3917651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of intravenous administration of FT-207 for gastric cancer].
    Otani Y; Yamanaka T; Kikuchi H; Namatame K; Yoshida K; Kataba Y; Maruyama Y; Watanabe H
    Gan To Kagaku Ryoho; 1985 Apr; 12(4):857-60. PubMed ID: 3920970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Regulation of enzyme activities involved in pyrimidine synthesis and its application to cancer chemotherapy].
    Shirasaka T; Fujii S
    Gan To Kagaku Ryoho; 1984 Mar; 11(3 Pt 2):760-8. PubMed ID: 6424581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of intravenous feeding on adjuvant chemotherapy--an experimental study on the distribution of 5-FU after injection of tegafur (1)].
    Kimoto M; Nagano H; Sano K
    Gan To Kagaku Ryoho; 1987 Jan; 14(1):135-9. PubMed ID: 3099649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Concentrations of 5-fluorouracil (5-FU) in serum and tissues at venous injection of tegafur or 5-FU--clinical study on colorectal cancer].
    Kojima T; Suzumura K; Kanemitsu T; Miyashita A; Inamura Y; Owa Y; Naruse T
    Gan To Kagaku Ryoho; 1998 Mar; 25(4):547-51. PubMed ID: 9530361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-Ethynyluracil (776C85): effects on the antitumor activity and pharmacokinetics of tegafur, a prodrug of 5-fluorouracil.
    Cao S; Baccanari DP; Joyner SS; Davis ST; Rustum YM; Spector T
    Cancer Res; 1995 Dec; 55(24):6227-30. PubMed ID: 8521418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serum concentration of 5-FU and tegafur (FT-207) after administration of tegafur (FT-207) suppository with the colostomy].
    Kimoto M; Nagano H; Gunge N; Murei T; Iwamoto S; Seo Y; Yamamoto Y; Sano K
    Gan To Kagaku Ryoho; 1987 Oct; 14(10):2853-8. PubMed ID: 3116942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic modulation of plasma 5-fluorouracil concentrations to potentiate the antitumor activity of continuous venous infusion of 5-fluorouracil.
    Fujii S; Fukushima M; Shimamoto Y; Shirasaka T
    Jpn J Cancer Res; 1989 Jun; 80(6):509-12. PubMed ID: 2503471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experimental studies on the optimal therapeutic mode of intra-arterial infusion of 5-fluorouracil. (1) Preparation of an animal model for continuous intra-arterial infusion and comparison of the therapeutic and adverse effects of 5-fluorouracil delivered by various modes].
    Ota J
    Gan To Kagaku Ryoho; 1983 Nov; 10(11):2353-61. PubMed ID: 6639097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-tumor effect of L-methionine-deprived total parenteral nutrition with 5-fluorouracil administration on Yoshida sarcoma-bearing rats.
    Goseki N; Endo M; Onodera T; Kosaki G
    Ann Surg; 1991 Jul; 214(1):83-8. PubMed ID: 1905913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parenteral nutrition decreases hepatic dihydropyrimidine dehydrogenase activity and modulates catabolism of 5-fluorouracil in rats.
    Taniguchi M; Yano M; Tsujinaka T; Ogawa A; Morita S; Kaneko K; Akiyama Y; Miki H; Monden M
    In Vivo; 2003; 17(3):219-23. PubMed ID: 12929570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.